Tysabri
Biogen Shares Hit New 52-Week High
Houston Chronicle - United States
... hit a new 52-week high Friday after analysts reaffirmed
positive ratings for the company, citing its multiple sclerosis
drug Tysabri and development pipeline. ...
0 Comments:
Post a Comment
<< Home